期刊文献+

石杉碱甲和卡巴拉汀治疗中重度阿尔茨海默病临床分析 被引量:3

原文传递
导出
摘要 目的比较石杉碱甲和卡巴拉汀治疗中重度阿尔茨海默病(AD)患者的疗效和药物副反应。方法 30例住院的中重度痴呆AD患者首先应用石杉碱甲100mgbid,3月后改用卡巴拉汀,开始3mgqd,1月后加到3mgbid。在应用石杉碱甲和卡巴拉汀3月后分别给予简易精神状态检查量表(MMSE)、总体衰退量表(GDS)和日常生活能力量表(ADL)量表评定,比较两药的疗效,并观察药物副反应。结果 30例中重度痴呆AD患者以石杉碱甲治疗3个月后MMSE与GDS评分无改善(P均>0.05),ADL评分降低(P<0.01);改卡巴拉汀组治疗3个月后MMSE评分明显提高(P<0.01),GDS和ADL评分明显降低(P<均0.01)。两药用后均无严重不良反应发生。结论石杉碱甲治疗中重度痴呆AD患者疗效欠理想,改用卡巴拉汀后疗效提高。两药副反应轻且相似。
作者 王英 冼易平
出处 《中国临床研究》 CAS 2013年第3期221-222,共2页 Chinese Journal of Clinical Research
  • 相关文献

参考文献5

二级参考文献28

  • 1徐维安,李建新,杨国龙,崔凤玉,谢关宝,顾瑜.石杉碱甲胶囊治疗阿尔采末氏病12例临床观察[J].中国民康医学,1999,0(5):25-26. 被引量:4
  • 2卞鑫,刘宇,姜卓颖,胡晓勤,朱国桢.盐酸甲氯芬酯联合石杉碱甲治疗轻中度血管性痴呆的临床观察[J].上海医药,2004,25(9):409-411. 被引量:14
  • 3谢素珍,马永兴,顾跃娣,俞正炎,杨俭英.石杉碱甲胶囊、片剂治疗增龄相关记忆障碍——117例对比分析[J].老年医学与保健,1999,5(4):171-173. 被引量:4
  • 4钟志耕,梁可珍.石杉碱甲治疗血管性痴呆29例临床观察[J].海南医学院学报,2004,10(4):251-252. 被引量:8
  • 5Feldman H,Gauthier S,Hecker J,et al. A 24-week, randomized,double-blind study of donepezil in moderate to severe Alzheimer's disease . Neurology, 2001,57 (4) : 613-620.
  • 6R oe sler M,Anand R,Cicin—Sain A,et a1.Efficacy and safety of rivastigmine in patients with Alzheimer’s disease:International randomized controlled trial[J].BMJ,1999;318(3):633—640.
  • 7Winblad B,Engedal K,Soininen H,et a1.A 1-year,randomized,placebo—controlled study of donepezil in patients with mild to moderate AD.Neurology.2001;57(3):489-495.
  • 8Krall JW,Sramek JJ,Cutler NR. Cholinesterase inhibition : A therapeutie strategy for Alzheimer's disease. Ann Pharmacother,1999;33(4):411-417.
  • 9Davis KL,Mohs RC,Marin D,et al. Cholinergic markers in elderly patients with early signs of Alzheimer's disease . JAMA, 1999;281(11) ,1401-1406.
  • 10Gilmor ML,Erickson JD,Varoqui H,et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vescular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease [J]. J Comp Neurol,1999;411(3) : 693-704.

共引文献76

同被引文献24

  • 1Weintraub D, Somogyi M, Meng X, et al. Rivastigmine in alzhe- imer's disease and Parkinson's disease dementia An ADAS-Cog factor analysis[J]. American journal of Alzheimer's disease and other dementias, 2011,26 (6) : 443-449.
  • 2Zara S,Rapino M,Sozio P, et al. Ibuprofen and lipoie acid co- drug 1 control Alzheimer's disease progression by down-regu lating protein kinase C epsilon-mediated metalloproteinase 2 and 9 levels in beta-amyloid infused Alzheimer's disease rat model. [J]. Brain research,2011,1412: 79-87.
  • 3Ahmed HH. Modulatory effects of vitamin E, acetyl-l-carni- fine and lipoic acid on new potential biomarkers for Alzhei- mer's disease in rat model[J]. Experimental and toxicologic pathology,2012,64(6) :549-556.
  • 4Xiao-rui C,Wen-xia Z,Xian Y.The behavioral,pathological and therapeutic features of the senescence-accelerated mouse prone 8strain as an Alzheimer's disease animal model[J].Ageing research reviews,2014,13(4):968-970.
  • 5Jesus J,Gomar,Maria T,Bobes-Bascaran.Utility of combinations of biomarkers,cognitive markers,and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative[J].Archives of general psychiatry,2011,68(9):628-630.
  • 6Arjun,Sharma,Anthony,Blank,Parashar.Health care policy and regulatory implications on medical device innovations:a cardiac rhythm medical device industry perspective[J].Journal of interventional cardiac electrophysiology:an international journal of arrhythmias and pacing,2013,36(2):486-491.
  • 7Jon O,Ebbert,Amenah A,Agunwamba.Counseling patients on the use of electronic cigarettes[J].Mayo Clinic proceedings,2015,90(01):128-134.
  • 8张瓅文,丁美会,杨喻晓,沈立荣.硫辛酸抗氧化性及其生理保健功能研究进展[J].科技通报,2009,25(4):432-436. 被引量:25
  • 9赵晓玲,刘艳,张仲,曾仲,高励,杨训永,邓茜,朱曦.阿托伐他汀联合美金刚治疗中重度阿尔茨海默病的疗效和安全性[J].中国实用神经疾病杂志,2010,13(21):9-11. 被引量:10
  • 10黄海华,李明秋,江皋轩,牟鑫,陈庆宏.卡巴拉汀治疗阿尔茨海默病的远期疗效观察[J].中华老年心脑血管病杂志,2011,13(4):310-312. 被引量:13

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部